Ductal Carcinoma In Situ

  • Isabel Alvarado-Cabrero


Ductal carcinoma in situ (DCIS) is a malignant, clonal proliferation of cells growing within the basement membrane-bound structures of the breast, with no evidence of invasion into the surrounding stroma [1]. The increased use of screening mammography has led to a significant increase in the diagnosis of earlier stage breast cancers, including DCIS.


Intraductal Carcinoma Low-grade Intermediate-grade High-grade Breast 


  1. 1.
    Pinder SE. Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation. Mod Pathol. 2010;23(suppl 2):S8–13.CrossRefPubMedGoogle Scholar
  2. 2.
    Sizioprkou KP. Ductal carcinoma in situ of the breast. Current concepts and future directions. Arch Pathol Lab Med. 2013;137:462–6.CrossRefGoogle Scholar
  3. 3.
    Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DSM. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst. 2008;23:1724–33.CrossRefGoogle Scholar
  4. 4.
    Kerlikowske K, Miglioretti DL, Ballard-Barbash R, Weaver DL, Buist DS, Barlow WE, et al. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol. 2003;21:4314–21.CrossRefPubMedGoogle Scholar
  5. 5.
    Sakorafas GH, Farley DR. Optimal management of ductal carcinoma in situ of the breast. Surg Oncol. 2003;12:221–40.CrossRefPubMedGoogle Scholar
  6. 6.
    Mardekian SK, Bombonati A, Palazzo JO. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions. Hum Pathol. 2016;49:114–23.CrossRefPubMedGoogle Scholar
  7. 7.
    Bellamy CO, McDonald C, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol. 1993;24:16–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med. 2009;133:15–25.PubMedGoogle Scholar
  9. 9.
    Pinder SE, Duggan C, Ellis IO, Cuzick J, Forbes JF, Bishop H, et al. A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer. 2010;103:94–100.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Fisher ER, Brown R. Intraductal signet ring cell carcinoma. A hitherto undescribed form of intraductal carcinoma of the breast. Cancer. 1985;55:2533–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Terada T. Clear cell variant of ductal carcinoma in situ of the breast. Breast J. 2012;18:279–80.CrossRefPubMedGoogle Scholar
  12. 12.
    Vranic S, Schmitt F, Sapino A, Costa JL, Reddy S, Castro M, et al. Apocrine carcinoma of the breast: a comprehensive review. Histol Histopathol. 2013;28:1393–409.PubMedGoogle Scholar
  13. 13.
    Tan PH, Lui GG, Chiang G, Yap WM, Poh WT, Bay BH. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions. Histopathology. 2004;45:343–51.CrossRefPubMedGoogle Scholar
  14. 14.
    D’Alfonso TM, Ginters PS, Liu YF, Shin SJ. Cystic hypersecretory (in situ) carcinoma of the breast: a clinicopathologic and immunohistochemical characterization of 10 cases with clinical follow-up. Am J Surg Pathol. 2014;32:45–53.CrossRefGoogle Scholar
  15. 15.
    Lari SA, Kuerer HM. Biological markers in DCIS and risk of breast recurrence: a systematic review. J Cancer. 2011;2:232–61.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Han K, Nofech-Mozes S, Narod S, Hanna W, Vesprini D, Saskin R, et al. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence. Clin Oncol (R Coll Radiol). 2012;24:183–9.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Isabel Alvarado-Cabrero
    • 1
  1. 1.Department of Pathology, Hospital de Oncologia, Centro Medico Nacional Siglo XXIInstituto Mexicano del Seguro SocialMexico CityMexico

Personalised recommendations